drugset / Trial / NCT03470077

Effect of Intravenous Nalbuphine on Emergence Agitation

NCT03470077

Phase 2 Completed 80 enrolled Assiut University
RandomizedParallel-groupDouble-blindPrevention

Summary

Our primary objective of this study is to compare the effect of administration of single dose of intravenous nalbuphine given with induction of anesthesia with intravenous nalbuphine given at the end of surgery on the incidence and severity of EA in children undergoing repair of rupture globe under general anesthesia. The secondary outcomes will include FLACC score for postoperative pain assessment, hemodynamic variables, any complications as postoperative vomiting (POV) and sedation and parents' satisfaction score.

Timeline

Start
2019-07-31
Primary completion
2020-09-30
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalbuphine Small molecule 0.1 mg/kg Intravenous

Indications

No indication recorded.